ARMC5 is part of an RPB1-specific ubiquitin ligase implicated in adrenal hyperplasia

Area of Science:

• Molecular Biology
• Cellular Biology
• Biochemistry

Background:

• The function of ARMC5 (Armadillo Repeat Containing 5) is largely unknown despite its association with pathological conditions.
• Previous studies suggested ARMC5 interacts with CUL3 and RPB1 (RNA polymerase II largest subunit).

Purpose of the Study:

• To elucidate the molecular function of ARMC5.
• To investigate the role of ARMC5 in RPB1 regulation and its implications in adrenal hyperplasia.

Main Methods:

• Co-immunoprecipitation assays to identify ARMC5-interacting proteins.
• Ubiquitination assays to assess RPB1 degradation.
• Gene expression analysis in wild-type and Armc5 knockout mice.
• Analysis of patient samples with primary bilateral macronodular adrenal hyperplasia (PBMAH).

Main Results:

• ARMC5, CUL3, and RBX1 form an active E3 ligase complex specifically targeting RPB1.
• Deletion of Armc5 significantly reduces RPB1 ubiquitination, leading to RPB1 accumulation and an enlarged RNA polymerase II pool.
• Compromised RPB1 degradation in adrenal glands dysregulates a subset of genes, mostly upregulating them.
• RPB1 is highly expressed in adrenal nodules of PBMAH patients with ARMC5 mutations, and mutant ARMC5 shows altered RPB1 binding.

Conclusions:

• Wild-type ARMC5 functions as part of a novel RPB1-specific E3 ligase complex.
• ARMC5 mutations disrupt RPB1 degradation, causing an enlarged RNA polymerase II pool and gene dysregulation.
• This mechanism is implicated in the pathogenesis of adrenal hyperplasia in both mouse models and human patients.